Back

Contemporary HIV-1 consensus Env with redesigned hypervariable loops promote antibody binding

Bai, H.; Lewitus, E.; Li, Y.; Dussupt, V.; Slike, B.; Mendez-Rivera, L.; Schmid, A.; Wieczorek, L.; Polonis, V.; Krebs, S. J.; Ake, J. A.; Vasan, S.; Joyce, M. G.; Townsley, S.; Rolland, M.

2023-11-19 microbiology
10.1101/2023.11.19.567729 bioRxiv
Show abstract

An effective HIV-1 vaccine must elicit broadly neutralizing antibodies (bnAbs) against the highly diverse Envelope glycoproteins (Env) present globally. Since Env with the longest hypervariable (HV) loops were more resistant to the cognate bnAbs than Env with shorter HV loops, we redesigned hypervariable loops for updated HIV-1 Env consensus sequences of subtypes B and C and circulating recombinant form AE (CRF01_AE). We reduced the length of V1HV, V2H, and V5HV while maintaining the integrity of the Env structure and glycan shield, and we modified V4HV to account for its diverse structural context. Redesiged HV loops consisted mainly of glycine and serine to limit strain-specific targeting. Redesigned consensus Env of subtype B or CRF01_AE demonstrated increased magnitude of binding responses to pooled plasma samples and representative bnAbs. Together with other antigen optimization techniques, consensus Env with redesigned hypervariable loops can improve future HIV-1 vaccine antigens to elicit bnAbs.

Matching journals

The top 3 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.